This section section considers submissions related to the frequency, distribution and health outcomes of urological related procedures, treatments and disease.
Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists’ recommendations for active treatment or active surveillance: a randomized clinical utility trial
Of the more than 1.1 million men diagnosed worldwide annually with prostate cancer, the majority have indolent tumors. Distinguishing between aggressive and indolent cancer is an important clinical challenge. ...
Citation: BMC Urology 2017 17:51